CervoMed Announces Publication in Neurology® Results Showing a Blood Test at Study Entry Identified Patients Who Demonstrated Substantial Response to Neflamapimod in Dementia with Lewy Bodies
/PRNewswire/ -- CervoMed Inc., a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced the...
United States John Alam Stephen Gomperts Prnewswire Cervomed Inc Diffusion Pharmaceuticals Inc Cervomed Inc
Source: prnewswire.com